enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.3200
-0.0269 (-7.75%)
At close: Dec 19, 2025, 4:00 PM EST
0.3400
+0.0200 (6.25%)
After-hours: Dec 19, 2025, 7:59 PM EST
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $6.47 million as of December 19, 2025. Its market cap has decreased by -87.78% in one year.
Market Cap
6.47M
Enterprise Value
-23.69M
1-Year Change
-87.78%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $6.47M, a decrease of -83.83%. That is a compound annual growth rate of -21.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 6.47M | -87.78% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |